Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application-Reference-Cited by-同舟云学术

Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application

Published:2023-07 Issue: Volume:138 Page:103057
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Henschel Pierre,Landwehr-Kenzel Sybille^ORCID,Engels Niklas^ORCID,Schienke Andrea,Kremer Jakob^ORCID,Riet Tobias^ORCID,Redel Nella,Iordanidis Konstantinos,Saetzler Valerie,John Katharina,Heider Miriam,Hardtke-Wolenski Matthias^ORCID,Wedemeyer Heiner^ORCID,Jaeckel Elmar^ORCID,Noyan Fatih^ORCID

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference46 articles.

1. Chimeric antigen receptor therapy;June;N. Engl. J. Med.,2018

2. Regulatory CAR-T cells in autoimmune diseases: progress and current challenges;Riet;Front. Immunol.,2022

3. CAR-tregs as a strategy for inducing graft tolerance;Wagner;Curr Transplant Rep,2020

4. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor;MacDonald;J. Clin. Invest.,2016

5. Prevention of allograft rejection by use of regulatory T cells with an MHC-specific chimeric antigen receptor;Noyan;Am. J. Transplant.,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effector memory–type regulatory T cells display phenotypic and functional instability;Science Advances;2024-09-06

2. Frontiers in CAR-T cell therapy for autoimmune diseases;Trends in Pharmacological Sciences;2024-09

3. Strategies and delivery systems for cell-based therapy in autoimmunity;Frontiers in Drug Delivery;2024-08-08

4. Graft-Specific Regulatory T Cells for Long-Lasting, Local Tolerance Induction;Cells;2024-07-19

5. Highlight of 2023: CAR T cells driving precision therapy for autoimmune disease;Immunology & Cell Biology;2024-05